期刊文献+

老年性痴呆大鼠血清的蛋白质组学研究 被引量:1

Proteomic analysis of alzheimer's disease Rats'serum
原文传递
导出
摘要 目的以老年性痴呆(AD)大鼠为研究对象,应用蛋白质组学方法在血清中筛选与AD密切相关的蛋白质,为研究AD的发病机制提供理论支持。方法通过Morris水迷宫记忆行为学筛选符合痴呆标准的AD大鼠模型,收集AD组大鼠及假手术组大鼠的血清后,去除血清中的高丰度蛋白质并进行蛋白质浓度的测定,之后进行双向凝胶电泳,挑选差异最为明显的蛋白质点进行肽质量指纹图谱分析,经数据库查询,鉴定差异蛋白质。结果经观察二维凝胶电泳图谱后,发现AD组大鼠与假手术组大鼠的血清中共有10个差异明显的蛋白质点,选取了2个最为明显的蛋白质点进行鉴定,分别为:血浆视黄醇结合蛋白前体,补体成分4,基因2(C4b)。结论C4b是新发现的与AD相关的蛋白质,有可能是潜在的AD标志物,有助于更深刻地理解AD的发病机制。 Objective Alzheimer's disease(AD) is a common and devastating disease and there is no readily available biomarker to aid diagnosis or to monitor disease progression. This study is to further understand the pathogenesis of Alzheimer's disease and seek new biomarkers for AD. Methods AD rats made by Aβ1-40 were assessed using the Morris water maze method. Sera of two groups were collected and albumin, IgG and sodium chloride were removed from the serum before concentration. Two-dimensional electrophoresis(2-DE) was performed on serum protein. Altered proteins were identified by matrix assisted laser desorption/ionization time of flight mass spectrometry(MALDI-TOF-MS). Results Compared with untreated samples, 10 altered proteins were found through 2-DE and all of them were down-regulated of which 2 were identified by MALDI-TOF-MS to be plasma retinol-binding protein precursor and complement component 4, gene 2 (C4b). Conclusion C4b may be the biomarker of AD and it may be helpful to understand the pathogenesis of AD.
出处 《国际生物医学工程杂志》 CAS 北大核心 2010年第3期138-141,共4页 International Journal of Biomedical Engineering
基金 国家自然科学基金资助项目(30770545) 天津市自然科学基金资助项目(09JCYBJCl3300)
关键词 血清 老年性痴呆 蛋白质组 补体成分4 基因2 Serum Alzheimer's disease Proteomics Complement component 4, gene 2
  • 相关文献

参考文献12

  • 1Kim SI,Voshol H,van Oostrum J,et al.Neuroproteomics:expression profiling of the brain's proteomes in health and disease[J].Neurochem Res,2004,29(6):1317-1331.
  • 2Huang Han-chang,Jiang Zhao-feng.Accumulated amyloid-beta peptide and hyperphosphorylated tau protein:relationship and links in Alzheimer's disease[J].J Alzheimers Dis,2009,16(1):15-27.
  • 3Vingtdeux V,Dreses-Werringloer U,Zhao Hai-tian,et al.Therapeutic potential of resveratrol in Alzheimer's disease[J].BMC Neurosci,2008,9 Suppl 2:S6.
  • 4Giovannelli L,Casamenti F,Scali C,et al.Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis[J].Neuroscience,1995,66(4):781-792.
  • 5Bradford MM.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding[J].Anal Biochem,1976,72:248-254.
  • 6Gorg A,Postel W,Gunther S.The current state of two-dimensional electrophoresis with immobilized pH gradients[J].Electrophoresis,1988,9(9):531-546.
  • 7Soprano DR,Pickett CB,Smith JE,et al.Biosynthesis of plasma retinol-binding protein in liver as a larger molecular weight precursory].J Biol Chem,1981,256(16):8256-8258.
  • 8Jung SM,Lee K,Lee JW,et al.Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF:candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease[J].Neurosci Lett,2008,436(2):153-157.
  • 9Walport MJ.Complement.First of two parts[J].N Engl J Med,2001,344(14):1058-1066.
  • 10Yu CY,Chung EK,Yang Yan,et al.Dancing with complement C4 and the RP-C4-CYP21-TNX(RCCX) modules of the major histocom-patibility complex[J].Prog Nucleic Acid Res Mol Biol,2003,75:217-292.

同被引文献8

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部